Keywords: fda, approves, ind, sr/quark, aki, drug, london

FDA approves IND for SR/Quark's AKI drug

Article | 26 March 2007

Print This

London, UK-based SR Pharma says that the US Food and Drug Administration has approved an Investigational New Drug application for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in